Latest "Biomarker discovery Driving technologies" News Stories

05:24 EDT 28th August 2014 | BioPortfolio

Here are the most relevant search results for "Biomarker discovery Driving technologies" found in our extensive news archives from over 250 global news sources.

More Information about Biomarker discovery Driving technologies on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about Biomarker discovery Driving technologies for you to read. Along with our medical data and news we also list Biomarker discovery Driving technologies Clinical Trials, which are updated daily. BioPortfolio also has a large database of Biomarker discovery Driving technologies Companies for you to search.

Showing "Biomarker discovery Driving technologies" News Articles 1–25 of 7,200+

Relevant

Bioanalytical CRO offers validation of proinflammatory, cytokine multiplex biomarker assays

In an industry first, bioanalytical CRO Tandem Labs has announced the availability of biomarker assays for human clinical studies using the Meso Scale Discovery V-PLEX biomarker platform, which have been already validated by Tandem in human serum. 

KineMed sets IPO range

Biomarker discovery company KineMed Inc. (Emeryville, Calif.) amended its IPO on NASDAQ and now plans to sell 4.5 million shares at $6.50-$7.50. At the $7 midpoint, the company would raise $31.5 million and be valued at $113.8 million. Feltl and Co.;...

Biomarker discovery may lead to new HIV treatment

(WHITECOAT STRATEGIES, LLC) Further analysis of a Phase II study of therapeutic HIV vaccine candidate Vacc-4x revealed a potential biomarker associated with participants who experienced a more profound viral load reduction after receiving the vaccine...

Cypher Genomics And Illumina, Inc. Enter Agreement To Facilitate Genomic Biomarker Discovery

KineMed pulls IPO

Biomarker discovery company KineMed Inc. (Emeryville, Calif.) withdrew its IPO on NASDAQ, citing "market conditions." The company declined to comment on future financing plans. Last month, KineMed amended its IPO to sell 4.5 million shares at $6.50-$...

Aggressive Breast Cancer Biomarker Identified

Two Northwestern University scientists have identified a biomarker strongly associated with basal-like breast cancer, a highly aggressive carcinoma that is resistant to many types of chemotherapy. The biomarker, a protein called STAT3, provides a sma...

07.28.14 -- Scientists Report Discovery Of Biomarker For HIV Vaccine; Teva Acquires Labrys

07/28/14 Bioresearch Online Newsletter

Biomarker Scout

Alessandra Cervino has joined Paris-based metagenomics specialist Enterome Bioscience SA as Head of Discovery.

WuXi PharmaTech, PBI In Biomarker Alliance

Gains access to PBI’s biomarker assays to support clinical testing services

Merck Data Could Support Use Of PD-L1 Biomarker In Lung Cancer

Data suggest the biomarker could be useful in lung cancer to help identify the 25% of patients who benefit the most, according to data presented at the American Association for Cancer Research meeting. But the biomarker looks less useful in melanoma.

Biomarker in aggressive breast cancer identified

Two Northwestern University scientists have identified a biomarker strongly associated with basal-like breast cancer, a highly aggressive carcinoma that is resistant to many types of chemotherapy. The biomarker, a protein called STAT3, provides a sma...

Cypher Genomics Announces the Appointment of Adam Simpson as President and COO

The company provides rapid and comprehensive annotation and interpretation of individual human genomes for biomarker discovery and clinical reporting.

New Biomarker for Esophageal Cancer

Findings from University Hospitals Case Medical Center and Case Western Reserve University School of Medicine at Digestive Disease Week 2014 A new biomarker for esophageal cancer shows promise in improving screening for this deadly disease and its pr...

WuXi PharmaTech Forms Biomarker Partnership with Targos

WuXi PharmaTech formed a clinical biomarker partnership with Targos GmbH, a German company that specializes in biomarker services. The partnership will focus on validation of biomarkers in cancer. Targos will provide know-how, services and standards...

Do people with autism struggle with driving?

In the first pilot study asking adults on the autism spectrum about their experiences with driving, researchers at Drexel University found significant differences in self-reported driving behaviors and perceptions of driving ability in comparison to...

Health Tip: Avoid Driving During Flood Warning

-- If the National Weather Service in your area has issued a flood warning, experts say you should avoid driving unless absolutely necessary. The Ready.gov website offers this advice about driving during a flood: Driving in just 6 inches of water...

Scientists identify biomarker strongly associated with aggressive breast cancer

Two Northwestern University scientists have identified a biomarker strongly associated with basal-like breast cancer, a highly aggressive carcinoma that is resistant to many types of chemotherapy. The biomarker, a protein called STAT3, provides a sma...

Tute Genomics biomarker discovery platform to support BYU's Alzheimer's disease genetics research

Tute Genomics announced that its genome annotation and discovery platform will support Brigham Young University's (BYU) efforts to advance Alzheimer's disease genetics research.

Biomarker Could Predict PTSD Risk

Blood expression levels of genes targeted by the stress hormones called glucocorticoids could be a physical measure, or biomarker, of risk for developing Post-Traumatic Stress Disorder (PTSD), according to a study conducted in rats by researchers at...

Driving Innovation through Federal Investments

Today, BIO submitted testimony to the Senate Committee on Appropriations on the importance of driving innovation through federal investments. Below are highlights of our written testimony. NIH:  A Driver of the Innovation Pipeline We must continue t...

Data Virtualization Powers Next Generation Sample Intelligence

Bio-IT World Contributed Commentary | With more than one billion samples stored in biobanks around the world, research advancements, genomics and biomarker development, and reduced research budgets are all driving the need for unified sample intelli...

Cypher Genomics and Illumina Enter Agreement to Facilitate Genomic Biomarker Discovery

SAN DIEGO, July 24, 2014 /PRNewswire/ -- Cypher Genomics, Inc., the genome informatics company, announced today a co-promotion agreement with Illumina to facilitate the development of genomic-based biomarkers from whole genome sequence data for precision medicine and clinical trials. Cypher Genomics and Illumina will jointly offer pharmaceutical companies, through Illumina's sales force, a so...

Driving simulator used to help learn how the visually impaired can drive safely

A diagnosis of hemianopia, or blindness in one half of the visual field in both eyes as the result of strokes, tumors or trauma often means the end of driving.In about half of the states in the United States and in many other countries, driving with...

Evotec, Roche sign three-year cancer companion diagnostics pact

Evotec AG and Roche will work together on biomarker discovery and validation for patient stratification in targeted cancer therapies.

Oncology Biomarker Testing: Why the UK Delay?

Amy Butcher investigates why the UK is lagging significantly behind Europe in the uptake of oncology biomarker testing — and looks at what the delays mean for pharma.


Search BioPortfolio:
Advertisement
Advertisement

News Quicklinks